HopeStage
Back to all studies
RecruitingNCT07238920

Brain-based neurofeedback and heart regulation in people with coronary disease and anxiety

About this titleRead the official source — NCT07238920
Device studyAges 18+China
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
ShenyangSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 19, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
56
Sponsor
Shenyang Medical College
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
China
Age range
Over 18 Years
Official registry ID
NCT07238920
Official title
Show the full official title

Closed-Loop Neurofeedback Targeting the Right Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety - A Randomized, Sham-Controlled Trial

Recruitment & locations

Currently recruiting

Shenyang

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Shenyang Medical College, a university.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies